| Product Name | NebuSelect™ Recombinant Mouse IL-17B, His-tag |
|---|---|
| Catalog Number | NBL-240632 |
| Alias/Synonyms | IL-17B; IL-17B; Cytokine CX1; IL20; interleukin 17B; interleukin 20; MGC138900; MGC138901; NIRF; ZCYTO7 |
| Appearance | see COA |
| Molecule Weight | His21-Phe180 |
| CAS | N/A |
| Solubility | Water Soluble |
| Storage | Short term 4℃; Long term -20℃. |
| Shelf Life | 2 years |
| Additional info 1 | Q9QXT6 |
| Additional info 2 |
| Catalog Numbe | Size | Price | Inventory Level | |
| NBL-240632-100ug | 100ug | Inquire | Inquire | |
| NBL-240632-1mg | 1mg | Inquire | Inquire | |
| NBL-240632-Customized Size | N/A | Inquire | Inquire |
Product Name:
NebuSelect™ Recombinant Mouse IL-17B, His-tag
Catalog#:
NBL-240632
Description:
NebuSelect™ Recombinant Mouse IL-17B, His-tag(Cat#NBL-240632) is expressed in E.coli with His tag at the N-Terminus.It contains His21-Phe180.
Species:
Mouse
Expression System:
E.coli
Molecular Weight:
The protein has a predicted MW of 19.1 kDa same as Bis-Tris PAGE result.
Target Name:
IL-17B; IL-17B; Cytokine CX1; IL20; interleukin 17B; interleukin 20; MGC138900; MGC138901; NIRF; ZCYTO7
Target Information:
IL-17A, the prototypic member of the IL-17 family, several experimental findings strongly support the role of the IL-17B/IL-17 receptor B (IL-17RB) pathway in tumorigenesis and resistance to anticancer therapies. IL-17B/IL-17RB expression patterns and biological activities in cancer and highlight issues that remain to be addressed to better characterize IL-17B and its receptor as potential targets for enhancing the effectiveness of the existing cancer therapies.
Amino Acid Sequence:
His21-Phe180
Purity:
>95%
Formulation:
see COA
Endotoxin:
<1EU/ug(LAL Method)
Storage:
4°C for short term.
-20°C for long term.
To get more information, please contact us freely.